- Home
- ECOR
ECOR
electroCore Inc.
as 03-28-2025 4:00pm EST
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | ROCKAWAY |
| Market Cap: | 57.5M | IPO Year: | 2018 |
| Target Price: | $25.50 | AVG Volume (30 days): | 216.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.32 - $19.49 | Next Earning Date: | 03-12-2025 |
| Revenue: | $25,182,000 | Revenue Growth: | 57.09% |
| Revenue Growth (this year): | 40.88% | Revenue Growth (next year): | 48.01% |
Stock Insider Trading Activity of electroCore Inc. (ECOR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Errico Thomas J. | ECOR | Director | Mar 17 '25 | Buy | $8.10 | 6,000 | $48,585.00 | 256,401 |
Latest electroCore Inc. News
ECOR Breaking Stock News: Dive into ECOR Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
electroCore Full Year 2024 Earnings: EPS Misses Expectations
GuruFocus.com
16 days ago
electroCore Inc (ECOR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Zacks
17 days ago
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
GlobeNewswire
17 days ago
electroCore Announces Full Year 2024 Financial Results
GlobeNewswire
23 days ago
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025
GlobeNewswire
24 days ago
electroCore to Participate at Upcoming Investor Conferences
GlobeNewswire
a month ago
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
GlobeNewswire
a month ago
electroCore’s Truvaga™ Now Available on Amazon®
Compare ECOR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ECOR electroCore Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.